众生药业 (002317)
Guangdong Zhongsheng Pharmaceutical Co.,Ltd.
K-Line Chart
No K-line data available
Company NameGuangdong Zhongsheng Pharmaceutical Co., Ltd.
Listing Date2009-12-11
Issue Price55RMB
Registered Capital84993.047710k RMB
Legal RepresentativeChen Yonghong
Registered AddressInformation Industry Park, West Lake Industrial Zone, Shilong Town, Dongguan City, Guangdong Province
IndustryTraditional Chinese Medicine II
Main BusinessPharmaceutical R&D, production, and sales
Company ProfileGuangdong Zhongsheng Pharmaceutical Co., Ltd. is a high-tech pharmaceutical enterprise dedicated to human health, listed on the A-share market. The company was founded in 1979 with a registered capital of 814.461076 million yuan and currently has ten subsidiaries. Since entering the capital market, the company has adhered to its strategy, pursuing dual-driven development through endogenous growth and external expansion. Regarding endogenous growth, the company actively deepens its presence in the provincial market and strives to expand into markets outside the province to promote business development. In terms of external expansion, the company focuses on R&D investment and mergers and acquisitions (M&A) integration across the industrial chain. Through M&A integration, the company has established an industrial chain layout from upstream raw materials to finished drug production, adding new momentum for its development. The company's business scope continues to expand, covering pharmaceutical R&D, production, and sales, medicinal herb cultivation, herbal slice processing, chemical raw material synthesis, and pharmaceutical trading.
Stock Details
1. Key Indicators
- Total Shares(W): 84993.05
- Circulating A-Shares(W): 76161.74
- Earnings Per Share(RMB): 0.3000
- Net Assets Per Share(RMB): 4.7415
- Operating Revenue(W RMB): 188875.39
- Total Profit(W RMB): 28733.63
- Net Profit Attributable to Parent(W RMB): 25057.80
- Net Profit Growth Rate(%): 68.40
- Weighted Return on Equity(%): 6.3000
- Operating Cash Flow Per Share(RMB): 0.1820
- Undistributed Profit Per Share(RMB): 1.1715
- Capital Reserve Per Share(RMB): 2.1350
2. Main Business
The main business covers:
- Pharmaceutical R&D
- Pharmaceutical Production
- Pharmaceutical Sales
3. Company Basic Information
- Company Name: Guangdong Zhongsheng Pharmaceutical Co., Ltd.
- Listing Date: 2009-12-11
- Industry: Pharmaceutical Manufacturing
- Address: Information Industry Park, Xihu Industrial Zone, Shilong Town, Dongguan City, Guangdong Province
- Website: www.zspcl.com
- Company Profile: The company was established as a joint stock limited company approved by the Guangdong Provincial People's Government General Office Document No. Yue Ban Han [2001]739 and the Guangdong Provincial Economic and Trade Commission Document No. Yue Jing Mao Supervision [2001]1086. The main promoter was the Industrial General Company, jointly initiated with eight natural persons: Zhang Shaori, Ye Huitang, Long Chaofeng, Cao Jiayue, Xiao Yan, Li Yujian, Zhao Xiping, and Huang Shibin. The company was registered with the Guangdong Provincial Administration for Industry and Commerce on December 31, 2001, with registration number 4400001009971 (changed to 440000000014746 on September 28, 2007, due to system upgrade). The registered capital was RMB 32 million.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Hong Kong Securities Clearing Company Ltd. | Northbound Funds | 2264.70 | 2.97 |
| 2 | Invesco Great Wall Trend Investment Mixed Securities Investment Fund (LOF) | Fund | 1646.83 | 2.16 |
| 3 | Invesco Great Wall Herun Mixed Securities Investment Fund (LOF) Class A | Fund | 1092.06 | 1.43 |
| 4 | Invesco Great Wall Multi-Dimensional Value Mixed Securities Investment Fund Class A | Fund | 963.79 | 1.27 |
| 5 | National Social Security Fund 604 Portfolio | Social Security Fund | 804.82 | 1.06 |
| 6 | Invesco Great Wall Hefeng Three-Year Holding Period Mixed Securities Investment Fund | Fund | 777.51 | 1.02 |
| 7 | Qianhai Kaiyuan Traditional Chinese Medicine Research Selected Equity Initiated Securities Investment Fund Class A | Fund | 308.04 | 0.40 |
| 8 | CCB High-End Medical Equity Securities Investment Fund Class A | Fund | 40.36 | 0.05 |
| 9 | Dacheng Zhihui Quantitative Multi-Strategy Flexible Allocation Hybrid Securities Investment Fund Class A | Fund | 2.81 | 0.00 |
| 10 | Taixin Smart Selection Quantitative Stock Selection Hybrid Initiated Securities Investment Fund Class A | Fund | 1.50 | 0.00 |
5. Concept Sectors
- Aging Care Concept
- Guangdong-Hong Kong-Macao Greater Bay Area
- Vitamins
- Intelligent Healthcare
- Generic Drugs
- NMN Concept
- Helicobacter Pylori
- Assisted Reproduction
- Hepatitis Concept
- Innovative Drugs
- Weight Loss Drugs
- Margin Trading & Securities Lending
- SME 300 Index
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information